The decision by Pharmac to switch funding of an antidepressant to a cheaper, generic one has some patients crying foul and experiencing the kind of side-effects the original drug was helping them avoid.
Psychotherapic Kyle MacDonald joins Carly Flynn on Saturday Fresh to talk about the decision.
After Pharmac withdrew subsidy for Effexor-XR last September, the government's pharmaceutical agency insisted that the replacement drug, Enlafax-XR, is safe.
But many patients are insisting that the drug is hindering their battle with depression rather than helping it.
Listen to the full interview with Kyle MacDonald above.